Rohto Pharmaceutical Co.,Ltd. (TYO:4527)

Japan flag Japan · Delayed Price · Currency is JPY
2,388.50
-5.50 (-0.23%)
Apr 28, 2026, 3:30 PM JST
1.75%
Market Cap 539.72B
Revenue (ttm) 335.80B
Net Income (ttm) 34.54B
Shares Out 225.96M
EPS (ttm) 148.61
PE Ratio 16.07
Forward PE 16.20
Dividend 46.00 (1.92%)
Ex-Dividend Date Mar 30, 2026
Volume 634,900
Average Volume 559,830
Open 2,402.50
Previous Close 2,394.00
Day's Range 2,356.50 - 2,402.50
52-Week Range 1,964.50 - 2,703.00
Beta -0.47
RSI 46.90
Earnings Date May 12, 2026

About Rohto Pharmaceutical

Rohto Pharmaceutical Co.,Ltd. manufactures and markets pharmaceutical products, cosmetics, and functional foods worldwide. The company provides eye care products, such as eye drops, care for contact lenses, and eye wash; and facial care products comprising face wash, lotions, and creams. It also offers medicine and medicated products for skin, lip balms, sunscreens, functional cosmetics, etc.; medicine for internal use, such as digestive and herbal medicines; regenerative medicines; OTC pharmaceutical products, including ophthalmic, dermatologi... [Read more]

Founded 1899
Employees 9,144
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4527
Full Company Profile

Financial Performance

In fiscal year 2025, Rohto Pharmaceutical's revenue was 308.63 billion, an increase of 13.95% compared to the previous year's 270.84 billion. Earnings were 31.01 billion, an increase of 0.23%.

Financial Statements

News

There is no news available yet.